The receptor tyrosine kinase ErbB2/HER2 governs CDK4 inhibitor sensitivity, timing and irreversibility of the G1/S transition

Journal:

Journal of Biological Chemistry

Published:

2025-10-27

DOI:

10.1016/j.jbc.2025.110865

Affiliations:

6

Authors:

4

Go to article

Institutions	Authors	Share
Institute for Protein Research (IPR), UOsaka, Japan	2.500000	0.63
Imperial College London (ICL), United Kingdom (UK)	0.500000	0.13
Exploratory Research Center on Life and Living Systems (ExCELLS), NINS, Japan	0.250000	0.06
National Institute for Basic Biology (NIBB), NINS, Japan	0.250000	0.06
The Graduate University for Advanced Studies (Sokendai), Japan	0.250000	0.06
Kyoto University, Japan	0.250000	0.06

Interested in Oncology and Carcinogenesis?